October 25, 2018
Rose
If the Chinese company's technology can do what executives say it can, then the competition it brings into the marketplace could drive down the already-plummeting cost of genome sequencing. Other industry news focuses on hospices, health care systems, and hospitals.
from Kaiser Health News https://ift.tt/2EKf4zB
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment